Analyst Price Target is $2.75
▲ +208.82% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Lucid Diagnostics in the last 3 months. The average price target is $2.75, with a high forecast of $3.00 and a low forecast of $2.50. The average price target represents a 208.82% upside from the last price of $0.89.
Current Consensus is
Buy
The current consensus among 2 polled investment analysts is to buy stock in Lucid Diagnostics. This Buy consensus rating has held steady for over two years.